RESISTANT ARTERIAL HYPERTENSION WITH SEVERE COMORBIDITY
(CASE FROM PRACTICE)
DOI:
https://doi.org/10.11603/1811-2471.2023.v.i4.14320Keywords:
resistant arterial hypertension, treatment, case from practiceAbstract
SUMMARY. The aim – to analyse of a clinical case with resistant arterial hypertension (AH), to reveal the main reasons for the ineffectiveness of its treatment.
Material and Methods. In this clinical case, the course of hypertension was complicated by its combination with diabetes mellitus (DM), obesity (OB), chronic renal failure (CKD), bronchial asthma (BA) and osteoarthritis (OA).
Results and Conclusions. Correction of the patient's lifestyle and treatment compliance are particularly important factors in the treatment of hypertension. Modern drug therapy is highly effective, affordable, based on the results of multicenter randomized studies, but there are no such studies comparing the effectiveness of specific treatment regimens, the choice of which is up to the family doctor.
References
International Society of Hypertension (2020). Hypertension Clinical Practice Guidelines (ISH, 2020). Medscape.
Unger T., Borghi C., & Charchar F. (2020). International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension, 75(6), 1334-1357. DOI: 10.1161/ HYPERTENSIONAHA.120.15026.
(2013). Evidence-Based Guideline for management arterial hypertension of European Society of Hypertension (ESH) of European Society of Cardiology (ESC). Hypertension, 31, 1281-1357.
(2014). Evidence-Based Guideline for management High Blood Pressurein Adults. Report Fromthe Panel Members Appointedtothe Eighth Joint National Committee (JNC 8), JAMA, 311(5), 507-520. DOI: 10.1001/jama.2013.
(2011). Hypertension: management of hypertension in adults in primary care. NICE Clinical Guidelines (CG127). Retrieved from: www.nice.org.uk/guidance/cg127ю.
Calhoun, D.A., Jones, D., & Textor, S. (2008). Resistant hypertension: diagnosis, evaluation, і treatment. American Heart Association Professional Education Committee of Council for High Blood Pressure Research. Hypertension, 51, 1403.
Moser, M., & Setaro, F. (2006). Resistant difficult-to-control hypertension. N. Engl. J. Med., 355, 389-392.
Myat, A., Qureshi, A.C., & Williams, B. (2012). Resistant hypertension. Clinical Review. BMJ, 345. DOI: 10. 1136/bmj.e7473 (Published 20 November 2012).
Nishizaka, M.K., Zaman, M.A., & Calhoun, D.A. (2003). Effectiveness of spironolactone in subjects with resistant hypertension. Am. J. Hypertens., 16, 925-930.
Viera, A. (2012). Resistant Hypertension. J. Am. Board. Fam. Med., 25, 4, 487-495.
Vongpatanasin, W. (2014). Resistant hypertension: a review of diagnosis and management. JAMA, 311, 2216.
